Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00463801
Status:
TERMINATED
Last Update Posted:
2011-03-24
First Post:
2007-04-19
Brief Title:
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multicentre Open Label Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections cSSTI Caused by Methicillin-resistant Staphylococcus Aureus MRSA
Status:
TERMINATED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Because of inadequate accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None